Skip to main content

Publisher: Elsevier

Volume 14, Number 4, 23 February 2004

Favourites:
ADD

Editorial Board
pp. 2-2(1)

Favourites:
ADD

Graphical Contents List
pp. 823-835(13)

Favourites:
ADD

Effective irreversible alkylating reagents based on the structure of clavulones
pp. 837-840(4)
Authors: Tanaka, H.; Kitade, M.; Iwashima, M.; Iguchi, K.; Takahashi, T.

Favourites:
ADD

Kringle 5 peptide-albumin conjugates with anti-migratory activity
pp. 841-845(5)
Authors: Leger, R.; Benquet, C.; Huang, X.; Quraishi, O.; van Wyk, P.; Bridon, D.

Favourites:
ADD

Mass-tag technology for monitoring of protein kinase activity using mass spectrometry
pp. 847-850(4)
Authors: Sonoda, T.; Shigaki, S.; Nagashima, T.; Okitsu, O.; Kita, Y.; Murata, M.; Katayama, Y.

Favourites:
ADD

A neural network based prediction of octanol-water partition coefficients using atomic5 fragmental descriptors
pp. 851-853(3)
Authors: Molnar, L.; Keseru, G.M.; Papp, A.; Gulyas, Z.; Darvas, F.

Favourites:
ADD
Favourites:
ADD

Diastereoselective synthesis and configuration-dependent activity of (3-substituted-cycloalkyl)glycine pyrrolidides and thiazolidides as dipeptidyl peptidase IV inhibitors
pp. 859-863(5)
Authors: Ashton, W.T.; Dong, H.; Sisco, R.M.; Doss, G.A.; Leiting, B.; Patel, R.A.; Wu, J.K.; Marsilio, F.; Thornberry, N.A.; Weber, A.E.

Favourites:
ADD

3-Amino-2-hydroxyamides and related compounds as inhibitors of methionine aminopeptidase-2
pp. 865-868(4)
Authors: Sheppard, G.S.; Wang, J.; Kawai, M.; BaMaung, N.Y.; Craig, R.A.; Erickson, S.A.; Lynch, L.; Patel, J.; Yang, F.; Searle, X.B.; Lou, P.; Park, C.; Kim, K.H.; Henkin, J.; Lesniewski, R.

Favourites:
ADD

Carbonic anhydrase inhibitors: The first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX
pp. 869-873(5)
Authors: Pastorekova, S.; Casini, A.; Scozzafava, A.; Vullo, D.; Pastorek, J.; Supuran, C.T.

Favourites:
ADD

Orally active anti-proliferation agents: novel diphenylamine derivatives as FGF-R2 autophosphorylation inhibitors
pp. 875-879(5)
Authors: Shimizu, T.; Fujiwara, Y.; Osawa, T.; Sakai, T.; Kubo, K.; Kubo, K.; Nishitoba, T.; Kimura, K.; Senga, T.; Murooka, H.; Iwai, A.; Fukushima, K.; Yoshino, T.; Miwa, A.

Favourites:
ADD

Inhibitors of multidrug resistance (MDR) have affinity for MDR substrates
pp. 881-885(5)
Authors: Zloh, M.; Kaatz, G.W.; Gibbons, S.

Favourites:
ADD

Obtaining higher transesterification rates with subtilisin Carlsberg in nonaqueous media
pp. 887-889(3)
Authors: Roy, I.; Sharma, A.; Gupta, M.N.

Favourites:
ADD

Mechanism of action of pyridazine analogues on protein tyrosine phosphatase 1B (PTP1B)
pp. 891-895(5)
Authors: Tjernberg, A.; Hallen, D.; Schultz, J.; James, S.; Benkestock, K.; Bystrom, S.; Weigelt, J.

Favourites:
ADD

Synthesis and biological evaluation of pyrrolo[2,1-c][1,4]benzodiazepine (PBD) C8 cyclic amine conjugates
pp. 901-904(4)
Authors: Masterson, L.A.; Croker, S.J.; Jenkins, T.C.; Howard, P.W.; Thurston, D.E.

Favourites:
ADD

A highly toxic morphine-3-glucuronide derivative
pp. 905-908(4)
Authors: Salvatella, M.; Arsequell, G.; Valencia, G.; Rodriguez, R.E.

Favourites:
ADD

Design and synthesis of 3,7-diarylimidazopyridines as inhibitors of the VEGF-receptor KDR
pp. 909-912(4)
Authors: Wu, Z.; Fraley, M.E.; Bilodeau, M.T.; Kaufman, M.L.; Tasber, E.S.; Balitza, A.E.; Hartman, G.D.; Coll, K.E.; Rickert, K.; Shipman, J.; Shi, B.; Sepp-Lorenzino, L.; Thomas, K.A.

Favourites:
ADD

A new series of potent oxindole inhibitors of CDK2
pp. 913-917(5)
Authors: Luk, K.; Simcox, M.E.; Schutt, A.; Rowan, K.; Thompson, T.; Chen, Y.; Kammlott, U.; DePinto, W.; Dunten, P.; Dermatakis, A.

Favourites:
ADD

Benzimidazolone p38 inhibitors
pp. 919-923(5)
Authors: Dombroski, M.A.; Letavic, M.A.; McClure, K.F.; Barberia, J.T.; Carty, T.J.; Cortina, S.R.; Csiki, C.; Dipesa, A.J.; Elliott, N.C.; Gabel, C.A.; Jordan, C.K.; Labasi, J.M.; Martin, W.H.; Peese, K.M.; Stock, I.A.; Svensson, L.; Sweeney, F.J.; Yu, C.H.

Favourites:
ADD

Epimerisation of lutein to 3'-epilutein in processed foods
pp. 925-928(4)
Authors: Deli, J.; Molnar, P.; Osz, E.; Toth, G.; Zsila, F.

Favourites:
ADD

Regioselective oxidation of 2-amino-3-aroyl-4,5-dialkylthiophenes by DMSO
pp. 929-933(5)
Authors: Joshi, E.; Chordia, M.D.; Macdonald, T.L.; Linden, J.; Olsson, R.

Favourites:
ADD

Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 1: Discovery and SAR study of 4-pyrazolylpiperidine side chains
pp. 935-939(5)
Authors: Shen D.-M.; Shu, M.; Mills, S.G.; Chapman, K.T.; Malkowitz, L.; Springer, M.S.; Gould, S.L.; DeMartino, J.A.; Siciliano, S.J.; Kwei, G.Y.; Carella, A.; Carver, G.; Holmes, K.; Schleif, W.A.; Danzeisen, R.; Hazuda, D.; Kessler, J.; Lineberger, J.; Miller, M.D.; Emini, E.A.

Favourites:
ADD

Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 2: Discovery of potent, selective, and orally bioavailable compounds
pp. 941-945(5)
Authors: Shen D.-M.; Shu, M.; Willoughby, C.A.; Shah, S.; Lynch, C.L.; Hale, J.J.; Mills, S.G.; Chapman, K.T.; Malkowitz, L.; Springer, M.S.; Gould, S.L.; DeMartino, J.A.; Siciliano, S.J.; Lyons, K.; Pivnichny, J.V.; Kwei, G.Y.; Carella, A.; Carver, G.; Holmes, K.; Schleif, W.A.; Danzeisen, R.; Hazuda, D.; Kessler, J.; Lineberger, J.; Miller, M.D.; Emini, E.A.

Favourites:
ADD

Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segment
pp. 947-952(6)
Authors: Shu, M.; Loebach, J.L.; Parker, K.A.; Mills, S.G.; Chapman, K.T.; Shen D.-M.; Malkowitz, L.; Springer, M.S.; Gould, S.L.; DeMartino, J.A.; Siciliano, S.J.; Salvo, J.D.; Lyons, K.; Pivnichny, J.V.; Kwei, G.Y.; Carella, A.; Carver, G.; Holmes, K.; Schleif, W.A.; Danzeisen, R.; Hazuda, D.; Kessler, J.; Lineberger, J.; Miller, M.D.; Emini, E.A.

Favourites:
ADD

Discovery and in vitro evaluation of potent TrkA kinase inhibitors: oxindole and aza-oxindoles
pp. 953-957(5)
Authors: Wood, E.R.; Kuyper, L.; Petrov, K.G.; Hunter, R.N.; Harris, P.A.; Lackey, K.

Favourites:
ADD

Novel arylsulfonamides possessing sub-picomolar HIV protease activities and potent anti-HIV activity against wild-type and drug-resistant viral strains
pp. 959-963(5)
Authors: Miller, J.F.; Furfine, E.S.; Hanlon, M.H.; Hazen, R.J.; Ray, J.A.; Robinson, L.; Samano, V.; Spaltenstein, A.

Favourites:
ADD

Lysyl 4-aminobenzoic acid derivatives as potent small molecule mimetics of plasminogen kringle 5
pp. 965-966(2)
Authors: Sheppard, G.S.; Kawai, M.; Craig, R.A.; Davidson, D.J.; Majest, S.M.; Bell, R.L.; Henkin, J.

Favourites:
ADD

Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency
pp. 967-971(5)
Authors: Beaulieu, P.L.; Bos, M.; Bousquet, Y.; DeRoy, P.; Fazal, G.; Gauthier, J.; Gillard, J.; Goulet, S.; McKercher, G.; Poupart, M.; Valois, S.; Kukolj, G.

Favourites:
ADD

Novel inhibitors of fatty acid oxidation as potential metabolic modulators
pp. 973-977(5)
Authors: Elzein, E.; Shenk, K.; Ibrahim, P.; Marquart, T.; Kerwar, S.; Meyer, S.; Ahmed, H.; Zeng, D.; Chu, N.; Soohoo, D.; Wong, S.; Leung, K.; Zablocki, J.

Favourites:
ADD

Synthesis and evaluation of S-4-(3-thienyl)phenyl-α-methylacetic acid
pp. 979-982(4)
Authors: Mittal, S.; Malde, A.; Selvam, C.; Arun, K.H.S.; Johar, P.S.; Jachak, S.M.; Ramarao, P.; Bharatam, P.V.; Chawla, H.P.S.

Favourites:
ADD

Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors incorporating substituted biphenyl P4 motifs
pp. 983-987(5)
Authors: Zhang, P.; Bao, L.; Zuckett, J.F.; Goldman, E.A.; Jia, Z.J.; Arfsten, A.; Edwards, S.; Sinha, U.; Hutchaleelaha, A.; Park, G.; Lambing, J.L.; Hollenbach, S.J.; Scarborough, R.M.; Zhu B.-Y.

Favourites:
ADD

Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors with improved functional activity
pp. 989-993(5)
Authors: Zhang, P.; Bao, L.; Zuckett, J.F.; Jia, Z.J.; Woolfrey, J.; Arfsten, A.; Edwards, S.; Sinha, U.; Hutchaleelaha, A.; Lambing, J.L.; Hollenbach, S.J.; Scarborough, R.M.; Zhu B.-Y.

Favourites:
ADD

4-Thio-5-bromo-2'-deoxyuridine: chemical synthesis and therapeutic potential of UVA-induced DNA damage
pp. 995-997(3)
Authors: Xu Y.-Z.; Zhang, X.; Wu, H.; Massey, A.; Karran, P.

Favourites:
ADD

Binding of -carbolines at imidazoline I2 receptors: a structure-affinity investigation
pp. 999-1002(4)
Authors: Glennon, R.A.; Grella, B.; Tyacke, R.J.; Lau, A.; Westaway, J.; Hudson, A.L.

Favourites:
ADD

Pyrazino[1,2-a]indoles as novel high-affinity and selective imidazoline I2 receptor ligands
pp. 1003-1005(3)
Authors: Chang-Fong, J.; Tyacke, R.J.; Lau, A.; Westaway, J.; Hudson, A.L.; Glennon, R.A.

Favourites:
ADD

Doxorubicin prodrug on the basis of tert-butyl cephalosporanate sulfones
pp. 1007-1010(4)
Authors: Veinberg, G.; Shestakova, I.; Vorona, M.; Kanepe, I.; Domrachova, I.; Lukevics, E.

Favourites:
ADD

Anti-inflammatory flavonoids and pterocarpanoid from Crotalaria pallida and C. assamica
pp. 1011-1014(4)
Authors: Ko, H.; Weng, J.; Tsao, L.; Yen, M.; Wang, J.; Lin C.-N.

Favourites:
ADD

Synthesis of angiogenesis-targeted peptide and hydrophobized polyethylene glycol conjugate
pp. 1015-1017(3)
Authors: Maeda, N.; Takeuchi, Y.; Takada, M.; Namba, Y.; Oku, N.

Favourites:
ADD

Cytochrome P450/NADPH-dependent formation of trans epoxides from trans-arachidonic acids
pp. 1019-1022(4)
Authors: Roy, U.; Loreau, O.; Balazy, M.

Favourites:
ADD

4-Substituted anilides as selective melatonin MT2 receptor agonists
pp. 1023-1026(4)
Authors: Epperson, J.R.; Deskus, J.A.; Gentile, A.J.; Iben, L.G.; Ryan, E.; Sarbin, N.S.

Favourites:
ADD

N-[1-Aryl-2-(1-imidazolo)ethyl]-guanidine derivatives as potent inhibitors of the bovine mitochondrial F1F0 ATP hydrolase
pp. 1027-1030(4)
Authors: Atwal, K.S.; Ahmad, S.; Ding, C.Z.; Stein, P.D.; Lloyd, J.; Hamann, L.G.; Green, D.W.; Ferrara, F.N.; Wang, P.; Rogers, W.L.; Doweyko, L.M.; Miller, A.V.; Bisaha, S.N.; Schmidt, J.B.; Li, L.; Yost, K.J.; Lan, H.; Madsen, C.S.

Favourites:
ADD

Benzodiazepine-based selective inhibitors of mitochondrial F1F0 ATP hydrolase
pp. 1031-1034(4)
Authors: Hamann, L.G.; Ding, C.Z.; Miller, A.V.; Madsen, C.S.; Wang, P.; Stein, P.D.; Pudzianowski, A.T.; Green, D.W.; Monshizadegan, H.; Atwal, K.S.

Favourites:
ADD

1,2-Benzothiazine 1,1-dioxide α-ketoamide analogues as potent calpain I inhibitors
pp. 1035-1038(4)
Authors: Bihovsky, R.; Tao, M.; Mallamo, J.P.; Wells, G.J.

Favourites:
ADD

The development of potent non-peptidic PTP-1B inhibitors
pp. 1039-1042(4)
Authors: Dufresne, C.; Roy, P.; Wang, Z.; Asante-Appiah, E.; Cromlish, W.; Boie, Y.; Forghani, F.; Desmarais, S.; Wang, Q.; Skorey, K.; Waddleton, D.; Ramachandran, C.; Kennedy, B.P.; Xu, L.; Gordon, R.; Chan, C.C.; Leblanc, Y.

Favourites:
ADD

Structure based design of a series of potent and selective non peptidic PTP-1B inhibitors
pp. 1043-1048(6)
Authors: Lau, C.K.; Bayly, C.I.; Gauthier, J.Y.; Li, C.S.; Therien, M.; Asante-Appiah, E.; Cromlish, W.; Boie, Y.; Forghani, F.; Desmarais, S.; Wang, Q.; Skorey, K.; Waddleton, D.; Payette, P.; Ramachandran, C.; Kennedy, B.P.; Scapin, G.

Favourites:
ADD

Non-peptide αv3 antagonists. Part 7: 3-Substituted tetrahydro-naphthyridine derivatives
pp. 1049-1052(4)
Authors: Wang, J.; Breslin, M.J.; Coleman, P.J.; Duggan, M.E.; Hunt, C.A.; Hutchinson, J.H.; Leu, C.; Rodan, S.B.; Rodan, G.A.; Duong, L.T.; Hartman, G.D.

Favourites:
ADD

Discovery and SAR development of 2-(phenylamino) imidazolines as postacyclin receptor antagonists
pp. 1053-1056(4)
Authors: Clark, R.D.; Jahangir, A.; Severance, D.; Salazar, R.; Chang, T.; Chang, D.; Jett, M.F.; Smith, S.; Bley, K.

Favourites:
ADD

Erratum to ''Synthesis of potent and selective 2-azepanone inhibitors of human tryptase'' Biorg. Med. Chem. Lett. 14 (2004) 309
pp. 1057-1057(1)
Authors: Zhao, G.; Bolton, S.; Kwon, C.; Hartl, K.; Seiler, S.; Slusarchyk, W.; Sutton, J.; Bisacchi, G.

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more